Several studies have found lower circulating myonectin levels in people with obesity compared to healthy people, as well as a negative association between myonectin and indicators of metabolic risk, including BMI, visceral fat content, and indexes of insulin resistance (200, 201). This evidence concerns the gene ERFE and obesity due to melanocortin 4 receptor deficiency.